Physician

Aaron Lee Boster, MD

According to 2025 Medicare claims, Aaron Boster, MD (NPI: 1760641740) practices neurology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is LEVEY INNOVATIVE THERAPEUTICS, LLC (NPI: 1801439310; TIN: 843384050) and primary practice location at 43235-5422.

Boster's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 98 traditional Medicare patients, billed 34,110 HCPCS/CPT codes, and received $1,116,254 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,142 prescription claims across 169 beneficiaries totaling $1,685,133 in drug costs, led by Kesimpta Pen (Ofatumumab). DME data shows 21 claims. Open Payments data shows 136 records totaling $783,309. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $92,440 to $1,116,254. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,627,295 and ending at $1,685,133. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $21,308 to $5,327.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	224	4,036	$92,440
2016	304	579	$58,420
2017	307	465	$44,104
2018	277	398	$39,295
2019	175	209	$18,054
2020	88	14,053	$627,018
2021	107	34,556	$1,474,081
2022	106	42,713	$1,451,529
2023	87	35,516	$1,161,066
2024	98	34,110	$1,116,254

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	141	995	$1,627,295
2016	154	1,408	$1,992,373
2017	197	2,019	$2,613,897
2018	189	1,579	$1,844,830
2019	177	1,240	$1,304,744
2020	130	840	$1,021,014
2021	135	1,795	$2,231,073
2022	163	1,981	$2,305,756
2023	157	1,988	$1,523,649
2024	169	2,142	$1,685,133

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	22	$2,508
2019	N/R	11	$642
2020	N/R	N/R	N/R
2021	N/R	12	$3,421
2022	N/R	13	$3,588
2023	N/R	N/R	N/R
2024	N/R	21	$7,132

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	55	113	$118
96413	Administration of chemotherapy into vein, 1 hour or less	25	62	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	63	155	$88
96415	Administration of chemotherapy into vein, each additional hour	22	43	$19
96375	Injection of additional new drug or substance into vein	22	79	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kesimpta Pen	Ofatumumab	23	965	$316,821
Enspryng	Satralizumab-Mwge	14	398	$245,272
Ampyra	Dalfampridine	32	960	$135,575
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	13	364	$54,228
Nuedexta	Dextromethorphan Hbr/Quinidine	19	1,029	$51,276

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	21	$7,132

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	101	$54,822	EMD Serono, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	35	$728,487	GENZYME CORPORATION
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Lee Boster, MD?

Tedicare shows public-source Medicare data for Aaron Lee Boster, MD (NPI 1760641740), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Lee Boster, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron Lee Boster, MD?

Aaron Lee Boster, MD is linked to LEVEY INNOVATIVE THERAPEUTICS, LLC (billing NPI 1801439310) in the available physician profile data.

Does Aaron Lee Boster, MD have Open Payments data?

Aaron Lee Boster, MD has 136 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.